-
Why SpaceX IPO plan is generating so much buzz
-
Thailand continues Cambodia strikes despite Trump truce calls
-
US envoy to meet Zelensky, Europe leaders in Berlin this weekend
-
North Korea acknowledges its troops cleared mines for Russia
-
US unseals warrant for tanker seized off Venezuelan coast
-
Cambodia says Thailand still bombing hours after Trump truce call
-
Machado urges pressure so Maduro understands 'he has to go'
-
Best Gold Investment Companies in USA Announced (Augusta Precious Metals, Lear Capital, Robinhood IRA and More Ranked)
-
Leinster stutter before beating Leicester in Champions Cup
-
World stocks mostly slide, consolidating Fed-fuelled gains
-
Crypto firm Tether bids for Juventus, is quickly rebuffed
-
Union sink second-placed Leipzig to climb in Bundesliga
-
US Treasury lifts sanctions on Brazil Supreme Court justice
-
UK king shares 'good news' that cancer treatment will be reduced in 2026
-
Wembanyama expected to return for Spurs in NBA Cup clash with Thunder
-
Five takeaways from Luigi Mangione evidence hearings
-
UK's king shares 'good news' that cancer treatment will be reduced in 2026
-
Steelers' Watt undergoes surgery to repair collapsed lung
-
Iran detains Nobel-prize winner in 'brutal' arrest
-
NBA Cup goes from 'outside the box' idea to smash hit
-
UK health service battles 'super flu' outbreak
-
Can Venezuela survive US targeting its oil tankers?
-
Democrats release new cache of Epstein photos
-
Colombia's ELN guerrillas place communities in lockdown citing Trump 'intervention' threats
-
'Don't use them': Tanning beds triple skin cancer risk, study finds
-
Nancy aims to restore Celtic faith with Scottish League Cup final win
-
Argentina fly-half Albornoz signs for Toulon until 2030
-
Trump says Thailand, Cambodia have agreed to stop border clashes
-
Salah in Liverpool squad for Brighton after Slot talks - reports
-
Marseille coach tips Greenwood as 'potential Ballon d'Or'
-
Draw marks 'starting gun' toward 2026 World Cup, Vancouver says
-
Thai PM says asked Trump to press Cambodia on border truce
-
Salah admired from afar in his Egypt home village as club tensions swirl
-
World stocks retrench, consolidating Fed-fuelled gains
-
Brazil left calls protests over bid to cut Bolsonaro jail time
-
Trump attack on Europe migration 'disaster' masks toughening policies
-
US plan sees Ukraine joining EU in 2027, official tells AFP
-
'Chilling effect': Israel reforms raise press freedom fears
-
Iran frees child bride sentenced to death over husband's killing: activists
-
No doubting Man City boss Guardiola's passion says Toure
-
Youthful La Rochelle name teen captain for Champions Cup match in South Africa
-
World stocks consolidate Fed-fuelled gains
-
British 'Aga saga' author Joanna Trollope dies aged 82
-
Man Utd sweat on Africa Cup of Nations trio
-
EU agrees three-euro small parcel tax to tackle China flood
-
Taylor Swift breaks down in Eras documentary over Southport attack
-
Maresca 'relaxed' about Chelsea's rough patch
-
France updates net-zero plan, with fossil fuel phaseout
-
Nowhere to pray as logs choke flood-hit Indonesian mosque
-
In Pakistan, 'Eternal Love' has no place on YouTube
Swiss seize window of opportunity on Trump tariffs
Switzerland will once again Friday try to talk its way out of punitive tariffs on its exports to the United States, which would have serious ramifications for Swiss jobs and businesses.
US Treasury Secretary Scott Bessent and China's Vice Premier He Lifeng are meeting in Geneva in an attempt to cool the trade war between the world's two biggest economies.
That has given the Swiss another chance to twist Washington's arm over the global wave of tariffs unleashed by US President Donald Trump on April 2, and comes a day after Britain reached a deal with the United States avoiding the worst of the punitive levies.
Swiss President Karin Keller-Sutter, who is also the country's finance minister, and Economy Minister Guy Parmelin are set to meet Bessent and US Trade Representative Jamieson Greer at a top hotel in Geneva.
Few details have been made public about the talks, but the Swiss were also set to meet Vice Premier He and were due to hold a press conference later on Friday.
Keller-Sutter and Parmelin already met Bessent and Greer in Washington late last month in a bid to negotiate lower tariffs.
- Watchmakers on borrowed time? -
Given the size of Switzerland's trade surplus -- exporting more to the United States than it imports from it -- the Trump administration has threatened to impose a 31 percent levy on Swiss exports to the United States.
This would be catastrophic for major sectors of Switzerland's economy, such as manufacturing and watchmaking.
For now, Washington is imposing a 10 percent levy on goods coming from Switzerland.
In 2024, the total value of Switzerland's goods exports to the United States was expected to reach 52.65 billion Swiss francs ($63.7 billion), with pharmaceutical products being the largest export.
Imports of goods from the United States were valued at 14.13 billion francs, according to Switzerland's Federal Office for Customs and Border Security.
Switzerland is the sixth-largest foreign investor in the United States, and ranks first in research and development, with pharmaceuticals being a key sector.
The United States is Switzerland's biggest trading partner after the European Union.
- Nespresso and big pharma -
There may be only so far that Keller-Sutter can get Washington to bend.
US Commerce Secretary Howard Lutnick said Thursday that Washington was likely to impose tariffs of more than 10 percent on trading partners with which it has a trade deficit.
"The 10 percent baseline is for those countries that have (a) balanced budget with us, that are the best," Lutnick told CNBC television. "Those who had trade deficits are going to have a higher tariff."
The potential repercussions of the Trump tariffs on Switzerland are still difficult to quantify.
When publishing its quarterly sales figures, food giant Nestle indicated that its Swiss-made Nespresso coffee pods were likely to be affected.
Pharmaceuticals were not targeted in the tariffs announced in early April -- though the Trump administration has blown hot and cold on such products since then.
Faced with the uncertainties, two Swiss heavyweights in the sector took their own initiative.
Novartis announced in mid-April that it was increasing its investments in the United States by $23 billion over five years, with Roche announcing shortly afterwards that it likewise planned to invest $50 billion over five years.
L.Davis--AMWN